Literature DB >> 12771076

Serotonin syndrome: a brief review.

Philippe Birmes1, Dominique Coppin, Laurent Schmitt, Dominique Lauque.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12771076      PMCID: PMC155963     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  26 in total

Review 1.  The serotonin syndrome and its treatment.

Authors:  P K Gillman
Journal:  J Psychopharmacol       Date:  1999       Impact factor: 4.153

2.  Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor.

Authors:  J A OATES; A SJOERDSMA
Journal:  Neurology       Date:  1960-12       Impact factor: 9.910

3.  Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.

Authors:  E Trindade; D Menon; L A Topfer; C Coloma
Journal:  CMAJ       Date:  1998-11-17       Impact factor: 8.262

Review 4.  Selective serotonin reuptake inhibitors: infrequent medical adverse effects.

Authors:  R J Goldberg
Journal:  Arch Fam Med       Date:  1998 Jan-Feb

5.  [Serotonin syndrome during fluoxetine poisoning in a patient taking moclobemide].

Authors:  M Chambost; L Liron; D Peillon; C Combe
Journal:  Can J Anaesth       Date:  2000-03       Impact factor: 5.063

Review 6.  Neuroleptic malignant syndrome: a review.

Authors:  A L Pelonero; J L Levenson; A K Pandurangi
Journal:  Psychiatr Serv       Date:  1998-09       Impact factor: 3.084

Review 7.  Herb-drug interactions.

Authors:  A Fugh-Berman
Journal:  Lancet       Date:  2000-01-08       Impact factor: 79.321

8.  [Serotonin syndrome secondary to the use of sertraline and metoclopramide].

Authors:  X Vandemergel; I Beukinga; P Nève
Journal:  Rev Med Brux       Date:  2000-06

Review 9.  The neuroleptic malignant and serotonin syndromes.

Authors:  J R Carbone
Journal:  Emerg Med Clin North Am       Date:  2000-05       Impact factor: 2.264

10.  Treatment of the serotonin syndrome with cyproheptadine.

Authors:  A Graudins; A Stearman; B Chan
Journal:  J Emerg Med       Date:  1998 Jul-Aug       Impact factor: 1.484

View more
  38 in total

1.  Ziprasidone--not an option for serotonin syndrome.

Authors:  Marshall E Cates
Journal:  CMAJ       Date:  2003-11-25       Impact factor: 8.262

2.  [The serotonin syndrome. Fatal course of intoxication with citalopram and moclobemide].

Authors:  S Cassens; E A Nickel; M Quintel; P Neumann
Journal:  Anaesthesist       Date:  2006-11       Impact factor: 1.041

3.  Triptan migraine treatments and antidepressants: risk of serotonin syndrome.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2006-09-20       Impact factor: 8.262

Review 4.  Serotonin toxicity: a short review of the literature and two case reports involving citalopram.

Authors:  G Talarico; G Tosto; S Pietracupa; E Piacentini; M Canevelli; G L Lenzi; G Bruno
Journal:  Neurol Sci       Date:  2011-04-14       Impact factor: 3.307

5.  Serotonin syndrome: not a benign toxidrome.

Authors:  Sarah Garside; Patricia I Rosebush
Journal:  CMAJ       Date:  2003-09-16       Impact factor: 8.262

6.  Neuroleptic Malignant Syndrome Associated with Lithium Toxicity.

Authors:  Vaibhav Patil; Rishab Gupta; Rohit Verma; Yatan Pal Singh Balhara
Journal:  Oman Med J       Date:  2016-07

7.  Deaths involving contraindicated and inappropriate combinations of serotonergic drugs.

Authors:  Jennifer L Pilgrim; Dimitri Gerostamoulos; Olaf H Drummer
Journal:  Int J Legal Med       Date:  2010-12-01       Impact factor: 2.686

8.  Serotonin syndrome: pills, thrills and shoulder aches.

Authors:  Malcolm Proudfoot; Joe Gormley
Journal:  BMJ Case Rep       Date:  2013-02-20

9.  Methylene blue-associated serotonin syndrome: a 'green' encephalopathy after parathyroidectomy.

Authors:  Michael Rowley; Kevin Riutort; David Shapiro; John Casler; Emir Festic; William D Freeman
Journal:  Neurocrit Care       Date:  2009-03-05       Impact factor: 3.210

10.  Characterization of serotonin-toxicity syndrome (toxidrome) elicited by 5-hydroxy-l-tryptophan in clorgyline-pretreated rats.

Authors:  Zhiyuan Ma; Gongliang Zhang; Chris Jenney; Swapna Krishnamoorthy; Rui Tao
Journal:  Eur J Pharmacol       Date:  2008-04-08       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.